Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group

OBJECTIVE: According to recent European Society of Medical Oncology, European Society of Gynaecological Oncology and European Society of Radiotherapy and Oncology guidelines, adjuvant vaginal brachytherapy (VB) is optional in patients with intermediate risk (IR) and high-intermediate risk (HIR) endo...

Descripción completa

Detalles Bibliográficos
Autores principales: Reboux, Pierre-Alain, Azaïs, Henri, Canova, Charles-Henry, Bendifallah, Sofiane, Ouldamer, Lobna, Raimond, Emilie, Hudry, Delphine, Coutant, Charles, Graesslin, Olivier, Touboul, Cyril, Collinet, Pierre, Bricou, Alexandre, Huchon, Cyrille, Daraï, Emile, Ballester, Marcos, Lévêque, Jean, Lavoué, Vincent, Koskas, Martin, Uzan, Catherine, Canlorbe, Geoffroy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543117/
https://www.ncbi.nlm.nih.gov/pubmed/31074238
http://dx.doi.org/10.3802/jgo.2019.30.e53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6543117/
https://www.ncbi.nlm.nih.gov/pubmed/31074238
http://dx.doi.org/10.3802/jgo.2019.30.e53

Ejemplares similares